Latest US Food and Drug Administration Stories
A drug for high-risk pregnant women that once cost between $10 to $20 per injection will next week cost $1,500 a dose, meaning the total cost during a pregnancy could be as much as $30,000.
MONMOUTH JUNCTION, N.J., March 9, 2011 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older.
Reynolds and Lorillard, the second- and third-biggest US cigarette makers, filed suit to block the FDA from receiving recommendations from an advisory committee that the cigarette makers claim have conflicts of interest.
EAST HANOVER, N.J., Feb.
Contrave Disallowed Pending Further Large-Scale Testing SILVER SPRING, Md., Feb.
SAN DIEGO, Jan. 27, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today a reduction of its US workforce of approximately 25%, or 66 employees.
PRINCETON, N.J., Jan. 20, 2011 /PRNewswire/ -- Soligenix, Inc.
Two American companies broke new ground this year by gaining regulatory approval to begin the first experiments using embryonic stem cells on people suffering from spinal cord injuries and blindness.
A US food safety agency warned consumers on Monday against eating alfalfa sprouts and spicy sprouts (a mixture of three types of sprouts) from Tiny Greens Organic Farm in Urbana, Illinois, after reports surfaced that the foods were tainted with salmonella, possibly behind the 89 cases found throughout the Midwest.
SAN DIEGO and WOODCLIFF LAKE, N.J., Dec. 22, 2010 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) and Eisai Inc. announced today the completion of an end-of-review meeting with the US Food and Drug Administration (FDA) for the lorcaserin New Drug Application (NDA).
- The governor of a province or people.